KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Equity Ratio: 2009-2025

Historic Equity Ratio for Exact Sciences (EXAS) over the last 15 years, with Sep 2025 value amounting to 0.42.

  • Exact Sciences' Equity Ratio fell 10.88% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year decrease of 10.88%. This contributed to the annual value of 0.41 for FY2024, which is 16.63% down from last year.
  • Latest data reveals that Exact Sciences reported Equity Ratio of 0.42 as of Q3 2025, which was down 0.47% from 0.43 recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Equity Ratio ranged from a high of 0.54 in Q1 2021 and a low of 0.41 during Q4 2024.
  • Over the past 3 years, Exact Sciences' median Equity Ratio value was 0.48 (recorded in 2024), while the average stood at 0.46.
  • Its Equity Ratio has fluctuated over the past 5 years, first climbed by 11.64% in 2021, then dropped by 16.63% in 2024.
  • Quarterly analysis of 5 years shows Exact Sciences' Equity Ratio stood at 0.51 in 2021, then fell by 3.56% to 0.49 in 2022, then decreased by 0.55% to 0.49 in 2023, then fell by 16.63% to 0.41 in 2024, then decreased by 10.88% to 0.42 in 2025.
  • Its Equity Ratio was 0.42 in Q3 2025, compared to 0.43 in Q2 2025 and 0.42 in Q1 2025.